{"id":51804,"date":"2023-09-20T09:25:28","date_gmt":"2023-09-20T09:25:28","guid":{"rendered":"https:\/\/medsname.com\/lanoxin\/"},"modified":"2026-05-01T10:49:11","modified_gmt":"2026-05-01T10:49:11","slug":"lanoxin","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/lanoxin\/","title":{"rendered":"Lanoxin"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 R\u0103spuns rapid \u2014 Ce este Lanoxin?<\/h3>\n<p style=\"margin:0;\"><strong>Lanoxin<\/strong> este un <strong>comprimat de digoxin\u0103 0,25 mg<\/strong> de la GSK \u2014 o <strong>glicozid\u0103 cardiac\u0103<\/strong> extras\u0103 din planta de degetar (Digitalis lanata). Digoxina este cel mai vechi medicament cardiovascular \u00eenc\u0103 utilizat pe scar\u0103 larg\u0103 \u00een clinic\u0103 (William Withering 1785). Utiliz\u0103ri moderne: <strong>insuficien\u021b\u0103 cardiac\u0103 cu frac\u021bie de ejec\u021bie redus\u0103 (IC-FER)<\/strong> \u2014 beneficiu simptomatic \u0219i reducerea spitaliz\u0103rilor (studiu DIG 1997, f\u0103r\u0103 beneficiu asupra mortalit\u0103\u021bii); <strong>controlul frecven\u021bei \u00een fibrila\u021bia atrial\u0103<\/strong> \u2014 \u00een special la pacien\u021bii sedentari sau \u00een v\u00e2rst\u0103 \u00een care intoleran\u021ba la beta-blocante limiteaz\u0103 alte op\u021biuni. <strong>Indice terapeutic \u00eengust<\/strong> \u2014 \u021bint\u0103 seric\u0103 0,5-0,9 ng\/mL \u00een IC; 0,8-2,0 ng\/mL \u00een FA. Toxicitate la &gt;2 ng\/mL, \u00een special \u00een insuficien\u021b\u0103 renal\u0103, hipokaliemie sau cu medicamente care interac\u021bioneaz\u0103. Doz\u0103 tipic\u0103: 62,5-250 mcg o dat\u0103 pe zi, ajustat\u0103 \u00een func\u021bie de nivel + r\u0103spunsul frecven\u021bei. Contraindicat \u00een sindromul Wolff-Parkinson-White cu FA, bloc AV gradul doi\/trei, bradicardie sever\u0103, cardiomiopatie hipertrofic\u0103 obstructiv\u0103, miocardit\u0103 activ\u0103.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n<h2 class=\"wp-block-heading\">Ce este Lanoxin?<\/h2>\n<p>Lanoxin este comprimate de digoxin 0,25 mg de la GSK, furnizate \u00een cutii de 30-90 de comprimate. Digoxinul este glicozida cardiac\u0103 de referin\u021b\u0103, extras\u0103 din frunzele plantei <em>Digitalis lanata<\/em> (degetul miresei l\u00e2nos). Predecesorul s\u0103u, digitalisul (din <em>Digitalis purpurea<\/em>), a fost introdus \u00een medicina occidental\u0103 de William Withering \u00een monografia sa revolu\u021bionar\u0103 din 1785 \u201cAn Account of the Foxglove\u201d \u2014 probabil primul text de farmacologie clinic\u0103 bazat pe dovezi. Digoxinul are o fereastr\u0103 terapeutic\u0103 \u00eengust\u0103 \u0219i necesit\u0103 individualizare atent\u0103, monitorizare a nivelului seric \u0219i vigilen\u021b\u0103 pentru toxicitate.<\/p>\n<h2 class=\"wp-block-heading\">Cum ac\u021bioneaz\u0103 digoxinul<\/h2>\n<p>Digoxinul inhib\u0103 <strong>ATPaza sodiu-potasiu<\/strong> (pompa Na\/K) de pe membranele celulelor miocardice. Efecte secundare:<\/p>\n<ul>\n<li><strong>Cre\u0219terea sodiului intracelular<\/strong> \u2014 reducerea secundar\u0103 a activit\u0103\u021bii schimb\u0103torului Na\/Ca, duc\u00e2nd la cre\u0219terea calciului intracelular<\/li>\n<li><strong>Inotropie pozitiv\u0103<\/strong> \u2014 contrac\u021bie cardiac\u0103 mai puternic\u0103. Efect u\u0219or, util \u00een insuficien\u021ba cardiac\u0103 sistolic\u0103.<\/li>\n<li><strong>Cre\u0219terea tonusului vagal<\/strong> \u2014 reducerea frecven\u021bei cardiace \u0219i \u00eencetinirea conduc\u021biei nodale AV. Acesta este principalul mecanism de control al frecven\u021bei \u00een FA.<\/li>\n<li><strong>Efecte neurohormonale<\/strong> \u2014 reducerea activit\u0103\u021bii simpatice, sc\u0103derea nivelului de noradrenalin\u0103 \u0219i renin\u0103 din plasm\u0103. Mecanismul beneficiului \u00een IC-FER.<\/li>\n<li><strong>F\u0103r\u0103 vasodilata\u021bie periferic\u0103 sau reducere direct\u0103 a post\u00eenc\u0103rc\u0103rii<\/strong> \u2014 spre deosebire de inhibitorii ACE, ARB \u0219i ARNI care reduc \u0219i post\u00eenc\u0103rcarea.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Dovezi \u0219i utiliz\u0103ri<\/h2>\n<p><strong>Insuficien\u021b\u0103 cardiac\u0103 cu frac\u021bie de ejec\u021bie redus\u0103 (IC-FER):<\/strong> <strong>Studiul DIG (1997)<\/strong> \u2014 digoxina la 6.800 de pacien\u021bi cu IC-FER deja trata\u021bi cu inhibitori ACE nu a produs nicio diferen\u021b\u0103 de mortalitate, dar a redus spitaliz\u0103rile pentru insuficien\u021b\u0103 cardiac\u0103 cu 28%. Analizele post-hoc au sugerat c\u0103 beneficiul este concentrat la niveluri serice de 0,5-0,9 ng\/mL; nivelurile mai mari (&gt;1,2 ng\/mL) au ar\u0103tat posibil\u0103 nocivitate. Ghidurile moderne plaseaz\u0103 digoxina ca <strong>terapie adjunctiv\u0103 pentru simptome persistente \u00een ciuda terapiei triple\/quadruple optime<\/strong> (inhibitor ACE\/ARB\/ARNI + beta-blocant + antagonist MR + inhibitor SGLT2).<\/p>\n<p><strong>Controlul frecven\u021bei \u00een fibrila\u021bia \u0219i flutterul atrial:<\/strong> Digoxina a fost medicamentul original pentru controlul ritmului \u00een fibrila\u021bia atrial\u0103. Preferin\u021ba modern\u0103 este pentru beta-blocante sau antagoni\u0219ti calcici non-dihidropiridinici (diltiazem, verapamil) pentru majoritatea pacien\u021bilor cu FA. Digoxina \u00ee\u0219i p\u0103streaz\u0103 locul \u00een cazurile de intoleran\u021b\u0103 la beta-blocante sau coexisten\u021b\u0103 cu insuficien\u021b\u0103 cardiac\u0103, care fac celelalte agen\u021bi problematici; este, de asemenea, util\u0103 la pacien\u021bii v\u00e2rstnici sedentari, unde se poate ob\u021bine un control adecvat al ritmului de repaus f\u0103r\u0103 necesitatea controlului ritmului la efort, necesar la pacien\u021bii activi. Utilizarea modern\u0103 adaug\u0103 adesea digoxin\u0103 la un beta-blocant, mai degrab\u0103 dec\u00e2t s\u0103 o foloseasc\u0103 singur\u0103.<\/p>\n<p><strong>Alte utiliz\u0103ri:<\/strong> folosit\u0103 istoric \u00een tahicardia supraventricular\u0103 (acum \u00eenlocuit\u0103 de adenozin\u0103 \u00een situa\u021bii acute \u0219i de abla\u021bie prin cateter definitiv).<\/p>\n<h2 class=\"wp-block-heading\">Dozaj<\/h2>\n<p><strong>Doza de \u00eenc\u0103rcare (digitalizare rapid\u0103, FA sau IC acut\u0103):<\/strong> rar folosit\u0103 \u00een practica modern\u0103. Dac\u0103 este necesar: 500 mcg pe cale oral\u0103, urmat\u0103 de 250-500 mcg la intervale de 6-8 ore, p\u00e2n\u0103 la un total de 0,75-1,5 mg \u00een 24 de ore.<\/p>\n<p><strong>Doza de \u00eentre\u021binere:<\/strong> 62,5-250 mcg o dat\u0103 pe zi. Doza tipic\u0103 pentru v\u00e2rstnici este de 62,5-125 mcg; doza tipic\u0103 pentru adul\u021bi tineri este de 125-250 mcg. Reduce\u021bi doza \u00een cazul insuficien\u021bei renale (digoxina este eliminat\u0103 70% renal).<\/p>\n<p><strong>Nivelul \u021bint\u0103 \u00een ser:<\/strong> <strong>0,5-0,9 ng\/mL \u00een IC-FER<\/strong>; 0,8-2,0 ng\/mL \u00een controlul ritmului \u00een FA. M\u0103sura\u021bi nivelul minim (8-12 ore dup\u0103 administrare), la 7 zile dup\u0103 modificarea dozei.<\/p>\n<p><strong>Monitorizare:<\/strong> electroli\u021bi \u0219i uree de baz\u0103 (potasiul \u0219i creatinina sunt critice), ECG, nivel de digoxin\u0103 la ziua 7, apoi la fiecare modificare a dozei \u0219i anual odat\u0103 stabilizat. Reevalua\u021bi la orice modificare a func\u021biei renale, la ini\u021bierea medicamentelor interac\u021bionate (amiodaron\u0103, verapamil, spironolacton\u0103, claritromicin\u0103) sau la suspiciunea clinic\u0103 de toxicitate (gre\u021buri, tulbur\u0103ri vizuale, confuzie, orice aritmie nou\u0103).<\/p>\n<p><strong>Toxicitate digoxin\u0103<\/strong> (nivel &gt;2 ng\/mL cu simptome):<\/p>\n<ul>\n<li>Precoce: gre\u021buri, v\u0103rs\u0103turi, anorexie, confuzie<\/li>\n<li>Clasic: tulbur\u0103ri vizuale galben-verzui (xantopsie), halouri<\/li>\n<li>Cardiac: orice aritmie \u2014 cel mai frecvent tahicardie atrial\u0103 cu bloc AV, ectopie ventricular\u0103, VT bidirec\u021bional\u0103<\/li>\n<li>Sever\u0103: aritmie amenin\u021b\u0103toare de via\u021b\u0103, hiperkaliemie (scurgerea de potasiu din pompa Na\/K inhibat\u0103 este un marker al severit\u0103\u021bii)<\/li>\n<\/ul>\n<p>Tratamentul toxicit\u0103\u021bii: \u00eentrerupe\u021bi administrarea de digoxin, corecta\u021bi potasiul \u0219i magneziul, lua\u021bi \u00een considerare <strong>fragmente de anticorpi specifice digoxinului (DigiFab)<\/strong> pentru aritmii amenin\u021b\u0103toare de via\u021b\u0103 sau potasiu &gt;5 mmol\/L \u00een intoxica\u021bia acut\u0103.<\/p>\n<h2 class=\"wp-block-heading\">Contraindica\u021bii<\/h2>\n<ul>\n<li>Sindromul Wolff-Parkinson-White cu fibrila\u021bie atrial\u0103 (poate accelera r\u0103spunsul ventricular prin calea accesorii, provoc\u00e2nd FV)<\/li>\n<li>Bloc AV de gradul doi sau trei f\u0103r\u0103 stimulator cardiac<\/li>\n<li>Cardiomiopatie hipertrofic\u0103 obstructiv\u0103 (HOCM) \u2014 efectul inotrop pozitiv agraveaz\u0103 obstruc\u021bia de ejectie<\/li>\n<li>Miocardit\u0103 activ\u0103<\/li>\n<li>Tahicardie ventricular\u0103 sau fibrila\u021bie ventricular\u0103 (efectul inotrop poate agrava)<\/li>\n<li>Bradicardie sever\u0103 sau sindromul sinusului bolnav<\/li>\n<li>Intoxica\u021bie cu digoxin la baz\u0103 (verifica\u021bi nivelul)<\/li>\n<li>Hipersensibilitate la digoxin<\/li>\n<\/ul>\n<p><strong>Sarcina:<\/strong> relativ sigur dac\u0103 este necesar; trece placent\u0103; utilizat ocazional \u00een tratamentul tahiaritmiilor fetale. <strong>Al\u0103ptarea:<\/strong> compatibil.<\/p>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<ul>\n<li><strong>Amiodaron\u0103<\/strong> \u2014 cre\u0219te nivelurile de digoxin cu 50-100%. \u00cenjum\u0103t\u0103\u021bi\u021bi doza de digoxin la \u00eenceperea amiodaronei.<\/li>\n<li><strong>Verapamil, diltiazem<\/strong> \u2014 cresc nivelurile de digoxin cu 50-70% \u0219i adaug\u0103 bradicardie. Reduce\u021bi doza; monitoriza\u021bi nivelurile.<\/li>\n<li><strong>Quinidine, dronedarone, propafenone<\/strong> \u2014 cresc nivelurile de digoxin semnificativ.<\/li>\n<li><strong>Spironolactone, eplerenone<\/strong> \u2014 cresc nivelurile de digoxin moderat (competi\u021bie P-glicoprotein\u0103).<\/li>\n<li><strong>Clarithromycin, erythromycin, azithromycin<\/strong> \u2014 cresc nivelurile de digoxin (efecte microbiom intestinal + P-gp). Monitoriza\u021bi.<\/li>\n<li><strong>Diuretice de ans\u0103 \u0219i tiazidice<\/strong> \u2014 hipokaliemia poten\u021biaz\u0103 toxicitatea digoxinului. Monitoriza\u021bi potasiul; ad\u0103uga\u021bi spironolacton\u0103 sau eplerenon\u0103 dac\u0103 este necesar.<\/li>\n<li><strong>Beta-blocante, CCB non-DHP<\/strong> \u2014 bradicardie \u0219i bloc AV aditive.<\/li>\n<li><strong>Cholestyramin\u0103, antiacide, t\u0103r\u00e2\u021be<\/strong> \u2014 reduce absorb\u021bia digoxinului. Separa\u021bi dozele cu 2 ore.<\/li>\n<li><strong>Rifampicin\u0103, Wort de Sf\u00e2ntul Ioan<\/strong> \u2014 scad nivelurile de digoxin prin inducerea P-gp.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Depozitare<\/h2>\n<p>P\u0103stra\u021bi Lanoxin sub 25\u00b0C. Depozita\u021bi \u00een loc inaccesibil copiilor.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">De ce am nevoie de analize de s\u00e2nge pentru Lanoxin?<\/h3>\n<p>Digoxinul are un <strong>interval terapeutic \u00eengust<\/strong> \u2014 nivelurile eficace \u0219i toxice sunt foarte apropiate, iar toxicitatea poate fi periculoas\u0103 pentru via\u021b\u0103. Nivelurile serice se m\u0103soar\u0103 la ini\u021biere (dup\u0103 7 zile de doz\u0103 stabil\u0103), la fiecare modificare de doz\u0103, la modific\u0103ri ale func\u021biei renale, la \u00eenceperea medicamentelor cu interac\u021biuni \u0219i la apari\u021bia oric\u0103rui simptom sugestiv pentru toxicitate (gre\u021buri, tulbur\u0103ri vizuale, aritmie nou\u0103).<\/p>\n<h3 class=\"wp-block-heading\">Care sunt semnele toxicit\u0103\u021bii digoxinului?<\/h3>\n<p>Precoce: pierderea apetitului, gre\u021buri, v\u0103rs\u0103turi. Clasice: modific\u0103ri vizuale galben-verzui sau halouri \u00een jurul surselor de lumin\u0103. Cardiace: orice palpita\u021bie sau aritmie nou\u0103. Neurologice: confuzie, oboseal\u0103. Dac\u0103 apare oricare dintre acestea, \u00eentrerupe\u021bi medicamentul \u0219i c\u0103uta\u021bi consult medical urgent \u2014 verifica\u021bi nivelul de digoxin, potasiu \u0219i ECG.<\/p>\n<h3 class=\"wp-block-heading\">Pot lua ibuprofen cu Lanoxin?<\/h3>\n<p>Utilizarea cronic\u0103 de AINS este riscant\u0103 \u2014 AINS reduc func\u021bia renal\u0103, cresc\u00e2nd nivelurile de digoxin (digoxinul este eliminat 70% renal). Folosi\u021bi paracetamol pentru durerea cronic\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Ce fac dac\u0103 uit o doz\u0103?<\/h3>\n<p>Lua\u021bi-l c\u00e2t mai cur\u00e2nd v\u0103 aminti\u021bi, cu excep\u021bia cazului \u00een care au trecut mai mult de 12 ore \u2014 \u00een acest caz, omite\u021bi doza ratat\u0103 \u0219i relua\u021bi tratamentul normal. Nu dubla\u021bi doza. O doz\u0103 ratat\u0103 rar destabilizeaz\u0103 TA sau ritmul cardiac.<\/p>\n<h3 class=\"wp-block-heading\">Unde pot cump\u0103ra Lanoxin online?<\/h3>\n<p>Pute\u021bi cump\u0103ra Lanoxin (digoxin 0,25 mg, 30-90 comprimate) de la MedsBase cu ambalaj discret \u0219i livrare la nivel mondial.<\/p>\n<h2 class=\"wp-block-heading\">Medicamente conexe pentru cardiologie \u0219i hipertensiune<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/aldactone\/\">Aldactone \u2014 Spironolacton\u0103 (antagonist MR neselectiv)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/amlopres-at\/\">Amlopres AT \u2014 Combina\u021bie de Amlodipin\u0103 + Atenolol<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/aten\/\">Aten \u2014 Atenolol (beta-blocant)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/cardace\/\">Cardace \u2014 Ramipril (inhibitor ACE)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/ecosprin\/\">Ecosprin \u2014 Aspirin\u0103 75\/150 mg<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/lipvas\/\">Lipvas \u2014 Atorvastatin\u0103 10\/20\/40 mg<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/high-blood-pressure-medication\/\"><strong>R\u0103sfoi\u021bi toate medicamentele pentru hipertensiune arterial\u0103<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 Dezaprobare medical\u0103.<\/strong> Aceast\u0103 pagin\u0103 are scop informativ \u0219i nu \u00eenlocuie\u0219te sfatul medical al unui medic calificat. Hipertensiunea, insuficien\u021ba cardiac\u0103 \u0219i aritmiile necesit\u0103 diagnostic, monitorizare \u0219i individualizarea dozei de c\u0103tre un medic \u2014 utiliza\u021bi \u00eentotdeauna beta-blocante sub \u00eendrumare medical\u0103.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>Afec\u021biuni cronice<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/concor-cor\/\">Concor Cor<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/voveran-sr\/\">Voveran SR<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/colospa\/\">Colospa<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/novonorm\/\">Novonorm<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/tamodex\/\">Tamodex<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Lanoxin este comprimatul de digoxin\u0103 0,25 mg de la GSK \u2014 glicozida cardiac\u0103 de referin\u021b\u0103, derivat\u0103 din planta de degetar \u0219i utilizat\u0103 continuu \u00een clinic\u0103 \u00eenc\u0103 din monografia lui William Withering din 1785. Roluri moderne: terapie adjunct\u0103 \u00een IC-FER c\u00e2nd simptomele persist\u0103 \u00een ciuda terapiei triple\/quadruple optime (studiu DIG 1997 \u2014 reducere cu 28% a spitaliz\u0103rilor pentru IC, f\u0103r\u0103 beneficiu asupra mortalit\u0103\u021bii); controlul frecven\u021bei \u00een fibrila\u021bia atrial\u0103 c\u00e2nd intoleran\u021ba la beta-blocante limiteaz\u0103 alte op\u021biuni. Fereastr\u0103 terapeutic\u0103 \u00eengust\u0103 \u2014 necesit\u0103 monitorizarea nivelului seric.<\/p>","protected":false},"featured_media":51805,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3260,3356],"product_tag":[3413,3414],"class_list":{"0":"post-51804","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-heart-blood-pressure","9":"product_cat-high-blood-pressure-medication","10":"product_tag-digoxin","11":"product_tag-lanoxin","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/51804","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=51804"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/51805"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=51804"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=51804"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=51804"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=51804"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}